{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:59:49Z","timestamp":1794491989601,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["TGM22CBDM05"],"award-info":[{"award-number":["TGM22CBDM05"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP15225"],"award-info":[{"award-number":["GGP15225"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-24-00762"],"award-info":[{"award-number":["22-24-00762"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-74-10087"],"award-info":[{"award-number":["20-74-10087"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Copper (Cu) is a vitally important micronutrient, whose balance between essential and toxic levels requires a tightly regulated network of proteins. Dysfunction in key components of this network leads to the disruption of Cu homeostasis, resulting in fatal disorders such as Wilson disease, which is caused by mutations in the hepatic Cu efflux transporter ATP7B. Unfortunately, the molecular targets for normalizing Cu homeostasis in Wilson disease remain poorly understood. Here, using genome-wide screening, we identified the cellular prion protein (PrP) as an important mediator of Cu toxicity in WD. Loss of ATP7B stimulates hepatic expression of PrP, which promotes endocytic Cu uptake, leading to toxic Cu overload. Suppression of PrP significantly reduces Cu toxicity in cell and animal models of Wilson disease. These findings highlight the critical regulatory role of PrP in copper metabolism and open new avenues for exploring the therapeutic potential of PrP suppression in Wilson disease.<\/jats:p>","DOI":"10.1038\/s41467-025-56740-x","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T10:02:18Z","timestamp":1739008938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prion protein promotes copper toxicity in Wilson disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-4486","authenticated-orcid":false,"given":"Raffaella","family":"Petruzzelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariantonietta","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-5931","authenticated-orcid":false,"given":"Antonio","family":"Masone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Lavigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9192-5749","authenticated-orcid":false,"given":"Anna","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Battipaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Vittoria","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Akdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirin","family":"Reinold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-9021","authenticated-orcid":false,"given":"Eugenio","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Carrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalaura","family":"Torella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-911X","authenticated-orcid":false,"given":"Enrico","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-950X","authenticated-orcid":false,"given":"Nicole","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-6341","authenticated-orcid":false,"given":"Emiliano","family":"Biasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-2812","authenticated-orcid":false,"given":"Ludmila V.","family":"Puchkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2325-0913","authenticated-orcid":false,"given":"Alessia","family":"Indrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina Y.","family":"Ilyechova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-2581","authenticated-orcid":false,"given":"Pasquale","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Zischka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-3733","authenticated-orcid":false,"given":"Roberto","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-1955","authenticated-orcid":false,"given":"Roman S.","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"56740_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nchembio.72","volume":"4","author":"BE Kim","year":"2008","unstructured":"Kim, B. E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4, 176\u2013185 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"56740_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.bbamcr.2012.02.011","volume":"1823","author":"T Nevitt","year":"2012","unstructured":"Nevitt, T., Ohrvik, H. & Thiele, D. J. Charting the travels of copper in eukaryotes from yeast to mammals. Biochim. Biophys. Acta 1823, 1580\u20131593 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"56740_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1172\/JCI45401","volume":"121","author":"H Zischka","year":"2011","unstructured":"Zischka, H. et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J. Clin. Investig. 121, 1508\u20131518 (2011).","journal-title":"J. Clin. Investig."},{"key":"56740_CR4","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1039\/C8MT00182K","volume":"10","author":"CM Saporito-Magri\u00f1\u00e1","year":"2018","unstructured":"Saporito-Magri\u00f1\u00e1, C. M. et al. Copper-induced cell death and the protective role of glutathione: the implication of impaired protein folding rather than oxidative stress. Metallomics 10, 1743\u20131754 (2018).","journal-title":"Metallomics"},{"key":"56740_CR5","doi-asserted-by":"crossref","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375,1254\u20131261 (2022).","DOI":"10.1126\/science.abf0529"},{"key":"56740_CR6","doi-asserted-by":"crossref","unstructured":"Lutsenko, S. Dynamic and cell-specific transport networks for intracellular copper ions. J. Cell Sci. 134, jcs240523 (2021).","DOI":"10.1242\/jcs.240523"},{"key":"56740_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2010.180","volume":"7","author":"SG Kaler","year":"2011","unstructured":"Kaler, S. G. ATP7A-related copper transport diseases-emerging concepts and future trends. Nat. Rev. Neurol. 7, 15\u201329 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"56740_CR8","doi-asserted-by":"crossref","unstructured":"Batzios, S. et al. Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter. Hum. Mol. Genet. 31, 4121\u20134130 (2022).","DOI":"10.1093\/hmg\/ddac156"},{"key":"56740_CR9","doi-asserted-by":"crossref","unstructured":"Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat. Rev. Cancer 22, 102\u2013113 (2022).","DOI":"10.1038\/s41568-021-00417-2"},{"key":"56740_CR10","doi-asserted-by":"crossref","unstructured":"Cz\u0142onkowska, A. et al. Nature Reviews Disease Primers article: Wilson disease. Nat. Rev. Dis. Primers 4, 21 (2018).","DOI":"10.1038\/s41572-018-0018-3"},{"key":"56740_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cgh.2013.09.025","volume":"12","author":"S Beinhardt","year":"2014","unstructured":"Beinhardt, S. et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin. Gastroenterol. Hepatol. 12, 683\u2013689 (2014).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"56740_CR12","doi-asserted-by":"publisher","first-page":"e98809","DOI":"10.1371\/journal.pone.0098809","volume":"9","author":"G Chandhok","year":"2014","unstructured":"Chandhok, G. et al. The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line. PLoS ONE 9, e98809 (2014).","journal-title":"PLoS ONE"},{"key":"56740_CR13","doi-asserted-by":"crossref","unstructured":"Polishchuk, E. V. et al. Activation of autophagy, observed in liver tissues from patients with Wilson disease and from atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology 156, 1173\u20131189.e5 (2019).","DOI":"10.1053\/j.gastro.2018.11.032"},{"key":"56740_CR14","doi-asserted-by":"crossref","unstructured":"Solier, S. et al. A druggable copper-signalling pathway that drives inflammation. Nature 617, 386\u2013394 (2023).","DOI":"10.1038\/s41586-023-06017-4"},{"key":"56740_CR15","doi-asserted-by":"publisher","first-page":"32453","DOI":"10.1073\/pnas.2006648117","volume":"117","author":"M Concilli","year":"2020","unstructured":"Concilli, M. et al. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B. Proc. Natl. Acad. Sci. USA 117, 32453\u201332463 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56740_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1566524043360645","volume":"4","author":"E Flechsig","year":"2004","unstructured":"Flechsig, E. & Weissmann, C. The role of PrP in health and disease. Curr. Mol. Med. 4, 337\u2013353 (2004).","journal-title":"Curr. Mol. Med."},{"key":"56740_CR17","unstructured":"Minikel, E. V. et al. Quantifying prion disease penetrance using large population control cohorts. Sci. Transl. Med. 8, 322ra9 (2016)."},{"key":"56740_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/356577a0","volume":"356","author":"H Bueler","year":"1992","unstructured":"Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577\u2013582 (1992).","journal-title":"Nature"},{"key":"56740_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nn.2483","volume":"13","author":"J Bremer","year":"2010","unstructured":"Bremer, J. et al. Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13, 310\u2013318 (2010).","journal-title":"Nat. Neurosci."},{"key":"56740_CR20","doi-asserted-by":"crossref","unstructured":"Grubenbecher, S., St\u00fcve, O., Hefter, H. & Korth, C. Prion protein gene codon 129 modulates clinical course of neurological Wilson disease. Neuroreport 17, 549\u2013552 (2006).","DOI":"10.1097\/01.wnr.0000209006.48105.90"},{"key":"56740_CR21","doi-asserted-by":"crossref","unstructured":"Medici, V. & LaSalle, J. M. Genetics and epigenetic factors of Wilson disease. Ann Transl. Med. 7, (Suppl 2) S58 (2019).","DOI":"10.21037\/atm.2019.01.67"},{"key":"56740_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-22","volume":"15","author":"N Forbes","year":"2014","unstructured":"Forbes, N. et al. Evidence for synergistic effects of PRNP and ATP7B mutations in severe neuropsychiatric deterioration. BMC Med. Genet. 15, 22 (2014).","journal-title":"BMC Med. Genet."},{"key":"56740_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1074\/jbc.M804755200","volume":"284","author":"SA Bellingham","year":"2009","unstructured":"Bellingham, S. A., Coleman, L. A., Masters, C. L., Camakaris, J. & Hill, A. F. Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. J. Biol. Chem. 284, 1291\u20131301 (2009).","journal-title":"J. Biol. Chem."},{"key":"56740_CR24","doi-asserted-by":"crossref","unstructured":"Varela-Nallar, L. et al. Induction of cellular prion protein gene expression by copper in neurons. Am. J. Physiol. Cell Physiol 290, C271\u2013C281 (2006).","DOI":"10.1152\/ajpcell.00160.2005"},{"key":"56740_CR25","doi-asserted-by":"crossref","unstructured":"McDonald, A. J. et al. Altered domain structure of the prion protein caused by Cu2+ binding and functionally relevant mutations: analysis by cross-linking, MS\/MS, and NMR. Structure 27, 907\u2013922.e5 (2019).","DOI":"10.1016\/j.str.2019.03.008"},{"key":"56740_CR26","doi-asserted-by":"crossref","unstructured":"Salzano, G., Giachin, G. & Legname, G. Structural consequences of copper binding to the prion protein. Cells 8, 770 (2019).","DOI":"10.3390\/cells8080770"},{"key":"56740_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0960-9822(01)00147-6","volume":"11","author":"WSS Perera","year":"2001","unstructured":"Perera, W. S. S. & Hooper, N. M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr. Biol. 11, 519\u2013523 (2001).","journal-title":"Curr. Biol."},{"key":"56740_CR28","doi-asserted-by":"publisher","first-page":"33107","DOI":"10.1074\/jbc.273.50.33107","volume":"273","author":"PC Pauly","year":"1998","unstructured":"Pauly, P. C. & Harris, D. A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107\u201333110 (1998).","journal-title":"J. Biol. Chem."},{"key":"56740_CR29","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1021\/bi011922x","volume":"41","author":"CS Burns","year":"2002","unstructured":"Burns, C. S. et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry 41, 3991\u20134001 (2002).","journal-title":"Biochemistry"},{"key":"56740_CR30","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","volume":"80","author":"F Voli","year":"2020","unstructured":"Voli, F. et al. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion. Cancer Res. 80, 4129\u20134144 (2020).","journal-title":"Cancer Res."},{"key":"56740_CR31","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1172\/JCI85226","volume":"126","author":"J Lichtmannegger","year":"2016","unstructured":"Lichtmannegger, J. et al. Methanobactin reverses acute liver failure in a rat model of Wilson disease. J. Clin. Investig 126, 2721\u20132735 (2016).","journal-title":"J. Clin. Investig"},{"key":"56740_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2353\/ajpath.2006.050312","volume":"168","author":"D Huster","year":"2006","unstructured":"Huster, D. et al. Consequences of copper accumulation in the livers of the Atp7b\u2212\/\u2212 (Wilson disease gene) knockout mice. Am. J. Pathol. 168, 423\u2013434 (2006).","journal-title":"Am. J. Pathol."},{"key":"56740_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/archneur.63.7.982","volume":"63","author":"U Merle","year":"2006","unstructured":"Merle, U., Stremmel, W. & Ge\u00dfner, R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch. Neurol. 63, 982\u2013985 (2006).","journal-title":"Arch. Neurol."},{"key":"56740_CR34","doi-asserted-by":"crossref","unstructured":"Masone, A. et al. A tetracationic porphyrin with dual anti-prion activity. iScience 26, 107480 (2023).","DOI":"10.1016\/j.isci.2023.107480"},{"key":"56740_CR35","doi-asserted-by":"crossref","unstructured":"Spagnolli, G. et al. Pharmacological inactivation of the prion protein by targeting a folding intermediate. Commun. Biol. 4, 1\u201316 (2021).","DOI":"10.1038\/s42003-020-01585-x"},{"key":"56740_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nbdi.2001.0400","volume":"8","author":"R Chiesa","year":"2001","unstructured":"Chiesa, R. et al. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol. Dis. 8, 279\u2013288 (2001).","journal-title":"Neurobiol. Dis."},{"key":"56740_CR37","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"56740_CR38","doi-asserted-by":"crossref","unstructured":"Nicastro, E. et al. Infantile ATP7B-related end-stage liver disease: an exceptional Wilson disease phenotype from consecutive generations. JPGN Rep. 2, e112 (2021).","DOI":"10.1097\/PG9.0000000000000112"},{"key":"56740_CR39","doi-asserted-by":"publisher","first-page":"e38327","DOI":"10.1371\/journal.pone.0038327","volume":"7","author":"LW Gray","year":"2012","unstructured":"Gray, L. W. et al. Urinary copper elevation in a mouse model of Wilson\u2019s disease is a regulated process to specifically decrease the hepatic copper load. PLoS ONE 7, e38327 (2012).","journal-title":"PLoS ONE"},{"key":"56740_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/BJ20061736","volume":"402","author":"DR Taylor","year":"2007","unstructured":"Taylor, D. R. & Hooper, N. M. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402, 17\u201323 (2007).","journal-title":"Biochem. J."},{"key":"56740_CR41","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1242\/jcs.046292","volume":"122","author":"YS Kang","year":"2009","unstructured":"Kang, Y. S., Zhao, X., Lovaas, J., Eisenberg, E. & Greene, L. E. Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway. J. Cell Sci. 122, 4062\u20134069 (2009).","journal-title":"J. Cell Sci."},{"key":"56740_CR42","doi-asserted-by":"publisher","first-page":"e5829","DOI":"10.1371\/journal.pone.0005829","volume":"4","author":"D Sarnataro","year":"2009","unstructured":"Sarnataro, D. et al. Lipid rafts and clathrin cooperate in the internalization of PrPC in epithelial FRT cells. PLoS ONE 4, e5829 (2009).","journal-title":"PLoS ONE"},{"key":"56740_CR43","doi-asserted-by":"crossref","unstructured":"Ren, K. et al. Flotillin-1 mediates PrPC endocytosis in the cultured cells during Cu2+ stimulation through molecular interaction. Mol. Neurobiol. 48, 631\u2013646 (2013).","DOI":"10.1007\/s12035-013-8452-4"},{"key":"56740_CR44","doi-asserted-by":"publisher","first-page":"e0157991","DOI":"10.1371\/journal.pone.0157991","volume":"11","author":"A Arkhipenko","year":"2016","unstructured":"Arkhipenko, A., Syan, S., Victoria, G. S., Lebreton, S. & Zurzolo, C. PrPC undergoes basal to apical transcytosis in polarized epithelial MDCK cells. PLoS ONE 11, e0157991 (2016).","journal-title":"PLoS ONE"},{"key":"56740_CR45","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.1021\/bi0501784","volume":"44","author":"T Miura","year":"2005","unstructured":"Miura, T., Sasaki, S., Toyama, A. & Takeuchi, H. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 44, 8712\u20138720 (2005).","journal-title":"Biochemistry"},{"key":"56740_CR46","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1074\/jbc.RA120.013690","volume":"295","author":"W Oosterheert","year":"2020","unstructured":"Oosterheert, W. & Gros, P. Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1). J. Biol. Chem. 295, 9502\u20139512 (2020).","journal-title":"J. Biol. Chem."},{"key":"56740_CR47","doi-asserted-by":"publisher","first-page":"C1525","DOI":"10.1152\/ajpcell.00480.2002","volume":"284","author":"M Arredondo","year":"2003","unstructured":"Arredondo, M., Mu\u00f1oz, P., Mura, C. V. & N\u00fa\u00f1ez, M. T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 284, C1525\u2013C1530 (2003).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"56740_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.gastro.2023.03.216","volume":"165","author":"C Einer","year":"2023","unstructured":"Einer, C. et al. ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson\u2019s disease rats. Gastroenterology 165, 187\u2013200.e7 (2023).","journal-title":"Gastroenterology"},{"key":"56740_CR49","doi-asserted-by":"crossref","unstructured":"Muchenditsi, A. et al. Systemic deletion of Atp7b modifies the hepatocytes\u2019 response to copper overload in the mouse models of Wilson disease. Sci. Rep. 11, 5659 (2021).","DOI":"10.1038\/s41598-021-84894-3"},{"key":"56740_CR50","doi-asserted-by":"crossref","unstructured":"Giedroc, D. P., Chen, X. & Apuy, J. L. Metal response element (MRE)-binding transcription factor-1 (MTF-1): Structure, function, and regulation. Antioxidants and Redox Signaling 3, 577\u2013596 (2001).","DOI":"10.1089\/15230860152542943"},{"key":"56740_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1301\/nr.2007.jul.335\u2013340","volume":"65","author":"MD Knutson","year":"2007","unstructured":"Knutson, M. D. Steap proteins: implications for iron and copper metabolism. Nutr. Rev. 65, 335\u2013340 (2007).","journal-title":"Nutr. Rev."},{"key":"56740_CR52","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S. et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat. Chem. 12, 929\u2013938 (2020).","DOI":"10.1038\/s41557-020-0513-5"},{"key":"56740_CR53","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/diagnostics12071635","volume":"12","author":"MJ Kim","year":"2022","unstructured":"Kim, M. J. et al. Cellular prion protein is closely associated with early recurrence and poor survival in patients with hepatocellular carcinoma. Diagnostics 12, 1635 (2022).","journal-title":"Diagnostics"},{"key":"56740_CR54","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4103\/NRR.NRR-D-24-00181","volume":"20","author":"A Masone","year":"2025","unstructured":"Masone, A., Zucchelli, C., Caruso, E., Musco, G. & Chiesa, R. Therapeutic targeting of cellular prion protein: toward the development of dual mechanism anti-prion compounds. Neural Regen. Res. 20, 1009\u20131014 (2025).","journal-title":"Neural Regen. Res."},{"key":"56740_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/BJ20130563","volume":"454","author":"L Tapella","year":"2013","unstructured":"Tapella, L. et al. Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases. Biochem. J. 454, 417\u2013425 (2013).","journal-title":"Biochem. J."},{"key":"56740_CR56","doi-asserted-by":"publisher","first-page":"100490","DOI":"10.1016\/j.jbc.2021.100490","volume":"296","author":"E Restelli","year":"2021","unstructured":"Restelli, E. et al. Activation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells. J. Biol. Chem.\u00a0296, 100490 (2021).","journal-title":"J. Biol. Chem."},{"key":"56740_CR57","doi-asserted-by":"publisher","first-page":"e42341","DOI":"10.1371\/journal.pone.0042341","volume":"7","author":"\u017d Strezoska","year":"2012","unstructured":"Strezoska, \u017d. et al. Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens. PLoS ONE 7, e42341 (2012).","journal-title":"PLoS ONE"},{"key":"56740_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"56740_CR59","doi-asserted-by":"crossref","unstructured":"Tarazona, S., Garc\u00eda-Alcalde, F., Dopazo, J., Ferrer, A. & Conesa, A. Differential expression in RNA-seq: a matter of depth. Genome Res. 21, 2213\u20132223 (2011).","DOI":"10.1101\/gr.124321.111"},{"key":"56740_CR60","first-page":"e140","volume":"43","author":"S Tarazona","year":"2015","unstructured":"Tarazona, S. et al. Data quality aware analysis of differential expression in RNA-seq with NOISeq R\/Bioc package. Nucleic Acids Res. 43, e140 (2015).","journal-title":"Nucleic Acids Res."},{"key":"56740_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"56740_CR62","doi-asserted-by":"crossref","unstructured":"Huang da, W., Sherman B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","DOI":"10.1038\/nprot.2008.211"},{"key":"56740_CR63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41589-018-0062-z","volume":"14","author":"T Xiao","year":"2018","unstructured":"Xiao, T. et al. Copper regulates rest-activity cycles through the locus coeruleus-norepinephrine system. Nat. Chem. Biol. 14, 655\u2013663 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"56740_CR64","doi-asserted-by":"crossref","unstructured":"Polishchuk, E. V. et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev. Cell.\u00a029 686\u2013700\u00a0(2014).","DOI":"10.1016\/j.devcel.2014.04.033"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56740-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T10:49:35Z","timestamp":1739011775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56740-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56740"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56740-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors disclose pending patent application priority filing (Applicant: Fondazione Telethon ETS, Inventor: RSP, Application #: IT 102024000028707) for the use of PrP as a target to treat disorders of copper metabolism and Wilson disease in particular. The specific aspect of manuscript covered in patent application includes the use of genetic and pharmacological suppression of PrP for reduction of copper toxicity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1468"}}